Infusion reactions and their management.

Abstract

Infliximab therapy should be optimized to minimize immunogenicity, to prevent infusion reactions, and to maintain clinical response. Based on best available evidence, strategies include minimizing the formation of ATI by administering infliximab as a multidose induction therapy followed by scheduled maintenance regiment, the use of concurrent… (More)

Topics

Cite this paper

@article{Mayer2006InfusionRA, title={Infusion reactions and their management.}, author={Lloyd F Mayer and Yuki Young}, journal={Gastroenterology clinics of North America}, year={2006}, volume={35 4}, pages={857-66} }